- Home
- NRC vs CYRX Comparison
NRC vs CYRX Comparison
Compare NRC & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRC
- CYRX
- Stock Information
- Founded
- NRC 1981
- CYRX 1999
- Country
- NRC United States
- CYRX United States
- Employees
- NRC N/A
- CYRX N/A
- Industry
- NRC Biotechnology: Commercial Physical & Biological Resarch
- CYRX Biotechnology: Pharmaceutical Preparations
- Sector
- NRC Health Care
- CYRX Health Care
- Exchange
- NRC Nasdaq
- CYRX Nasdaq
- Market Cap
- NRC 426.3M
- CYRX 381.6M
- IPO Year
- NRC N/A
- CYRX N/A
- Fundamental
- Price
- NRC $17.17
- CYRX $7.86
- Analyst Decision
- NRC
- CYRX Buy
- Analyst Count
- NRC 0
- CYRX 7
- Target Price
- NRC N/A
- CYRX $13.14
- AVG Volume (30 Days)
- NRC 114.1K
- CYRX 446.9K
- Earning Date
- NRC 02-11-2025
- CYRX 11-07-2024
- Dividend Yield
- NRC 2.80%
- CYRX N/A
- EPS Growth
- NRC N/A
- CYRX N/A
- EPS
- NRC 1.12
- CYRX N/A
- Revenue
- NRC $144,155,000.00
- CYRX $226,113,000.00
- Revenue This Year
- NRC N/A
- CYRX N/A
- Revenue Next Year
- NRC N/A
- CYRX $7.92
- P/E Ratio
- NRC $15.29
- CYRX N/A
- Revenue Growth
- NRC N/A
- CYRX N/A
- 52 Week Low
- NRC $16.74
- CYRX $5.32
- 52 Week High
- NRC $42.18
- CYRX $20.11
- Technical
- Relative Strength Index (RSI)
- NRC 35.82
- CYRX 53.97
- Support Level
- NRC $16.74
- CYRX $7.44
- Resistance Level
- NRC $18.31
- CYRX $8.37
- Average True Range (ATR)
- NRC 0.80
- CYRX 0.63
- MACD
- NRC -0.22
- CYRX 0.02
- Stochastic Oscillator
- NRC 13.46
- CYRX 51.66
About NRC National Research Corporation (Delaware)
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.